Thomas A. Waldmann, chief emeritus of the NCI Lymphoid Malignancies Branch and NIH Distinguished Investigator, died Sept. 25. He was 91.
Martin “Mac” Cheever, a Fred Hutchinson Cancer Research Center physician-scientist who was a pioneer in the development of immunotherapies, died on Sept. 23 from complications following heart surgery. He was 77. Friends and colleagues note Cheever’s calm demeanor, generosity and wit. As an oncologist, he was respected for his work as one of the first […]
Franco Muggia, a drug developer and former director of NYU Langone’s Perlmutter Cancer Center, died unexpectedly on Sept. 8.
John F. Potter, founder of the Georgetown Lombardi Comprehensive Cancer Center, died June 28, at MedStar Georgetown University Hospital, the site of his greatest professional triumphs. He was 95.
José Baselga, an expert in the development of molecular targeted agents and an executive at AstraZeneca, died of Creutzfeldt-Jakob, an extremely rare, rapidly progressing, degenerative brain disorder.
Emil J Freireich was a big man in stature, with a booming voice. He was one of the last of the 60 original members of the American Society of Clinical Oncology.
When I started my fellowship at MD Anderson Cancer Center in 1980, Dr. Freireich headed the Department of Developmental Therapeutics.
“Humans cannot live without hope. Hopelessness is the greatest trauma a person has to suffer.”—Emil J Freireich, MD
When we decided to write a book together about the history and impact of NCI-designated cancer centers since passage of the 1971 National Cancer Act, we both agreed that one of the first people we would interview was Joe Simone.
Joe Simone was oncology's polymath. Skilled and adept in patient care, scientific and clinical discovery, administrative leadership, education as well as mentoring to a generation of oncologists through his writings.
